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Volume 49, Number 5S Poster Presentations 23SResults: A total of 170 patients (95 males / 75 females) with a mean
age of 55  1 years were implanted. With both unilateral and bilateral
stimulation, there were significant intra-operative decreases in both systolic
and diastolic BP, along with HR. These therapeutic results were maintained
at one year follow-up (n49) at which time a large percentage of patients
(53%) were being treated unilaterally and there were no differences in results
between unilateral and bilateral stimulation:
SBP (mmHg) DBP (mmHg) HR (bpm)
Baseline 181  2 104  1 75  1
Intra-Operative (vs
Baseline)
Unilateral 32  2* 17  1*# 11  1*#
Bilateral 34  2* 18  1* 8  1*
One Year Follow-Up
(vs Baseline)
Unilateral 24  5* 15  3* 8  2*
Bilateral 19  8* 12  4* 7  2*
*p  0.01 vs Baseline.
#p0.05 vs. Bilateral.
Two-year follow-up data (n32) indicated a sustained systolic BP reduction
of 23  6 mmHg [p  0.001 vs. baseline].
Conclusions: Baroreceptor stimulation has sustained efficacy in de-
creasing both systolic and diastolic blood pressure in patients with resistant
hypertension. Similar results were attained with unilateral stimulation sug-
gesting single-sided implantation may be an acceptable clinical alternative in
the future.
Author Disclosures: J. Blebea, CVRx; C. Kaufman, CVRx.
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The Forgotten Pectoralis Minor Syndrome: Report of 100 Operations
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Objective: Pectoralis minor syndrome (PMS), first described in 1945,
is another cause of pain and paresthesia in the upper extremity. Its symptoms
mimick thoracic outlet syndrome (TOS). Between 2005 and 2007, more
than 75% of patients referred to us for TOS were found to have PMS, either
alone or combinated with TOS. We report 100 PM tenotomy operations in
these patients.
Methods: There were 100 pectoralis minor (PM) tenotomies per-
formed as the only procedure in 76 patients (24 bilateral). Diagnosis was
made by history of pain or tenderness below the clavicle and in the axilla plus
physical findings of tenderness over the PM tendon. Other common symp-
toms were upper extremity pain, paresthesia, and weakness, similar to
symptoms found in TOS. Diagnosis was confirmed by a positive response to
a PM muscle block with lidocaine. PM tenotomy was performed as an
outpatient under local anesthesia with heavy sedation through a 5-7 cm
transaxillary incision.
Results:History and physical exam separated patients into two groups:
52 operations for PMS alone; 48 for combined PMS and TOS. Symptoms
common to both groups were paresthesia and pain in upper extremity and
anterior chest wall (p0.05). Symptoms of occipital headache, neck and
supraclavicular pain were present in 81-96% of the combined group but only
31-50% of the PM-alone group and were much milder in the later group
(p.001). PM tenderness was present in almost all patients in both groups,
but positive responses to TOS provocative maneuvers were milder and less
frequent in the PM-alone group (p.008). 1-3 year success rates for
PM-alone were 81% good-excellent, 11% fair, and 8% failed; for PMS&TOS
group results were 31% good-excellent, 19% fair, and 50% failed. The only
complications were three wound infections. Most patients returned to work
within a few days. Subsequently thoracic outlet decompression was per-
formed in 62% of failed patients in the PMS&TOS group.
Conclusion: PMS should be considered in all patients presenting with
symptoms of TOS. The importance of recognizing PMS is that many of
these patients can be successfully treated with a relatively risk-free procedure
thereby avoidingmore invasive thoracic outlet operations and their potential
complications. When PMS accompanies TOS the two can be operated upon
simultaneously.Author Disclosures: R.J. Sanders, None; N.M. Rao, None.Lower Extremity Revascularization: Endo and Open
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Background: Changes in nitinol stent design and conformation have
been introduced to increase radial force and avoid loss of integrity in
femoro-popliteal (F-P) occlusions.
Objective: To compare long-term patency and frequency of fractures
in different nitinol F-P stents.
Methods: Two Groups of nitinol F-P stent were compared: Group I,
continuous elicoidal covered (ePTFE) stent and Group II, bare no-spiral
stents. All stents implanted for F-P obstruction in 2001-2008 were re-
viewed. Patency was investigated by duplex ultrasound and Stent integrity
using double projection x-ray with high-resolution images with Extended
and flexed leg position. The association between fractures and patency,
timing from implantation, calcification, lesion length and patients’ charac-
teristic was compared.
Results: A total of 102 F-P lesions were stented (mean age 70.6years,
males 66%): 59 inGroup I and 43 inGroup II. The 2Groups were similar for
baseline characteristics, lesion morphology and indications. Mean lesion
length was 132mm (IQR 80-180). At 32 months, assisted patency was 68%,
without no differences between II Groups. Sixty-nine patients were available
for stent integrity analysis. Twenty-five (36%) stent fractures were detected,
more frequent in Group I (20/41; 49%) than in Group II (5/28; 18%), 95%
CI 1.39-13.8; OR 4.3,p0.01. Overall, 15 (21.7%) fractured stents were
still patent. In patients available for stent integrity, assisted patency rate at 32
months was 73% in Group I vs 65% Group II (p0.88) . Logistic regression
showed that longer lesions (HR 1.11; 95% CI1.00-1.024; p 0.013) were the
only strongly negative predictors of patency in Group II while, failed to
confirm any statistically association between length of lesion and patency in
Group I.
Conclusion: Different design in F-P stents, spiral or not, offers the
same patency in mid and long term. Nevertheless, spiral stent deals better in
longer lesions but the high radial force increasing the fracture rate is a major
concern. Further design research and improvement of material resistance are
required to achieve satisfactory long-term results in F-P area.
Author Disclosures: M. Lenti, None; E. Cieri, None; P. De Rango,
None; G. Isernia, None; P. Bonanno, None; M. Fischer, None; P. Cao,
None.
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Midterm Results with Endovascular Popliteal Artery Aneurysm Repair
with ePTFE Covered Stent Grafts
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Objective: Early success has been demonstrated with endovascular
repair for popliteal artery aneurysms (PAA) with the Viabahn endoprosthe-
sis. This purpose of this report is to assess the midterm results of endovas-
cular PAA repair with ePTFE covered stent grafts.
Methods: From June 2004 to January 2009, 40 patients (mean age 75
years) underwent endovascular repair of 52 PAAs (mean diameter 2.5 cm).
Patients with contraindications to antiplatelet or anticoagulant therapy, no
in-line tibial artery runoff, and acute limb ischemia were excluded. Proce-
dures were performed under local anesthesia using ipsilateral percutaneous
antegrade arterial access. All patients received 75 mg/day of clopidogrel
afterwards. Follow-up assessments included direct clinical examination and
duplex ultrasonography performed at yearly intervals after the procedure.
Patency, secondary patency, freedom from reintervention, limb salvage, and
late complications were assessed.
Results: Mean and median follow-up were 25 and 23 months, respec-
tively (range 1 - 49). Reintervention rate was 19% but no reinterventions
have been performed beyond 18 months of follow-up. No stent-graft
thromboses occurred beyond 8 months follow-up. No limb loss was ob-
served.
